Golub Capital announced that as sole lead arranger, sole bookrunner and administrative agent it provided a GOLD financing and co-investment equity to support the acquisition of Flexan by Linden Capital Partners
GOLD financings are Golub Capital’s One-Loan Debt facilities.

”As a leading contract manufacturer, Flexan has positioned itself to take advantage of OEM’s focus on accelerating product development while streamlining costs, but it is also advantaged within its niche by having established manufacturing capabilities offshore,” said Stefano Robertson, managing director and the head of Golub Capital’s healthcare finance team. “With their successful experiences in contract and private label manufacturing, as well as their stable of networked operating executives, Linden is very well positioned to help the Company achieve their growth objectives and we are thrilled to invest in this company alongside of them.”

Michael Farah, a principal at Linden Capital Partners, said, “Golub provided a financing solution that offered certainty and efficiency to our process. This is the second deal we’ve closed together in the last six months and our fifth overall. We look forward to building on our strong and growing partnership.”

Chicago-headquartered Flexan is a global manufacturer of high-precision silicone and rubber parts predominately serving the medical device industry.